Skip to content

Clinical trials

Urogenital Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20112
20151
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Steba Biotech S.A.2
The Netherlands Cancer Institute2
University Medical Center Groningen2
Aragon Pharmaceuticals, Inc.1
Bioniche Life Sciences Inc.1
Blue Earth Therapeutics Ltd1
Eli Lilly and Company1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms11
Neoplasms6
Neoplasms by Site6
Prostatic Neoplasms5
Male Urogenital Diseases4
Prostatic Diseases4
Urologic Neoplasms4
Carcinoma3
Genital Diseases, Male3
Genital Neoplasms, Male3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.